2022
DOI: 10.1016/j.imu.2022.100969
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 analytics: Towards the effect of vaccine brands through analyzing public sentiment of tweets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 36 publications
0
6
0
Order By: Relevance
“…Additional machine learning techniques for polarity classification were Microsoft Azure cognitive services, Amazon Web Services (AWS), and Baidu’s AipNLP [ 59 , 64 , 75 ]. Deep learning techniques mainly used convolutional neural networks, recurrent neural networks, bidirectional long short-term memory (LSTM), and Bidirectional Encoder Representations from Transformers [ 63 , 65 , 66 , 68 , 71 , 77 ].…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Additional machine learning techniques for polarity classification were Microsoft Azure cognitive services, Amazon Web Services (AWS), and Baidu’s AipNLP [ 59 , 64 , 75 ]. Deep learning techniques mainly used convolutional neural networks, recurrent neural networks, bidirectional long short-term memory (LSTM), and Bidirectional Encoder Representations from Transformers [ 63 , 65 , 66 , 68 , 71 , 77 ].…”
Section: Resultsmentioning
confidence: 99%
“…Nineteen sentiment analysis studies were based on machine learning, and they trained machine learning classifiers by annotating tweets in the data set [59][60][61][62][63][64][65][66][67][68][69][70][71][72][73][74][75][76][77]. Machine learning approaches used supervised classification algorithms to extract information regarding sentiment polarity.…”
Section: Sentiment/emotion Analysismentioning
confidence: 99%
See 2 more Smart Citations
“…All nations now share the shared objective of eradicating COVID-19 and resuming daily operations. Since the pandemic's start, several research teams at significant pharmaceutical corporations and academic institutions throughout the globe have been creating vaccines [4]. WHO has granted emergency use authorizations for eight COVID-19 vaccines, including Sinovac, Sinopharm/BIBP, Moderna, AstraZeneca/Oxford, Johnson & Johnson, Covishield, and Pfizer/BioNTech.…”
Section: Introductionmentioning
confidence: 99%